Press Conference: Allegations Against 3M Corporation of Possible "Negligence and Recklessness" in Testing of Proven Anti-"Superbug"/Staph ("MRSA") Infection Detection Device - U.S. Food and Drug Administration Investigation and Public Hearings Sought
By The Porton Group, PRNEMonday, May 9, 2011
MINNEAPOLIS, Minnesota, May 10, 2011 -
When: Wednesday, May 11th 9:30 AM (O930) Central Daylight Time 10:30 AM (1030) Eastern Daylight Time 3:30 PM (1530) U.K. Time Call-in Numbers: U.S. Callers: 1-866-890-4243 European Callers: 1-707-595-2672 Back-up if Difficulty Calling in: 1-612-548-3440 Where: Hotel Ivy, Mozart Room, 201 South 11th Street, Minneapolis, MN 55415 Who: Robert R. Hopper, Robert R. Hopper & Associates, Minneapolis, MN Lanny J. Davis, Lanny J. Davis & Associates, Washington, D.C. (Former White House Special Counsel) Subject: Allegations Against 3M Corporation of Possible "Negligence and Recklessness" in Testing of Proven Anti-"Superbug"/Staph ("MRSA") Infection Detection Device - U.S. Food and Drug Administration Investigation and public Hearings Sought
Letter to U.S. FDA plus public petition for investigation and hearings
and documents supporting allegations to be released and posted at
www.mrsa-injustice.com
For futher information call: U.S. Media: Robert R. Hopper & Associates: 763-476-5809, robertr.hopper at gmail.com. Maddie Melendez: +1-202-756-8293, mmelendez at lannyjdavis.com. European Media: Catherine Nicholls: +44-7789-644-979, catherine at tetra-strategy.co.uk
Filed under: Biotechnology, Health, Health Care / Hospitals, Pharmaceuticals
Tags: May 10, Minneapolis, Minnesota, The Porton Group
Tags: May 10, Minneapolis, Minnesota, The Porton Group
YOUR VIEW POINT